Vaccitech Statistics

Share Statistics

Vaccitech has 38.55M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	38.55M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	1.67%
Shares Floating	28.3M
Failed to Deliver (FTD) Shares	6,675
FTD / Avg. Volume	0.91%

Short Selling Information

The latest short interest is 120.86K, so 0% of the outstanding shares have been sold short.

Short Interest	120.86K
Short % of Shares Out	n/a
Short % of Float	0.34%
Short Ratio (days to cover)	2.49

Valuation Ratios

The PE ratio is -2.03 and the forward PE ratio is null. Vaccitech's PEG ratio is 0.

PE Ratio	-2.03
Forward PE	n/a
PS Ratio	8.28
Forward PS	n/a
PB Ratio	0.95
P/FCF Ratio	-4.15
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Vaccitech.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.09.

Current Ratio	8.03
Quick Ratio	8.03
Debt / Equity	0.09
Debt / EBITDA	10.21
Debt / FCF	-0.4
Interest Coverage	-22.19

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$453.61K
Profits Per Employee	$-1.85M
Employee Count	33
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	-153K
Effective Tax Rate	0.25%

Stock Price Statistics

The stock price has increased by 58.73% in the last 52 weeks. The beta is -0.27, so Vaccitech's price volatility has been lower than the market average.

Beta	-0.27
52-Week Price Change	58.73%
50-Day Moving Average	3.35
200-Day Moving Average	2.6
Relative Strength Index (RSI)	49.91
Average Volume (20 Days)	731,881

Income Statement

In the last 12 months, Vaccitech had revenue of 14.97M and earned -61.07M in profits. Earnings per share was -1.55.

Revenue	14.97M
Gross Profit	n/a
Operating Income	1.18M
Net Income	-61.07M
EBITDA	1.18M
EBIT	n/a
Earnings Per Share (EPS)	-1.55

Full Income Statement

Balance Sheet

The company has 110.66M in cash and 12.01M in debt, giving a net cash position of 98.66M.

Cash & Cash Equivalents	110.66M
Total Debt	12.01M
Net Cash	98.66M
Retained Earnings	-237.66M
Total Assets	142M
Working Capital	97.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.94M and capital expenditures -892K, giving a free cash flow of -29.83M.

Operating Cash Flow	-28.94M
Capital Expenditures	-892K
Free Cash Flow	-29.83M
FCF Per Share	-0.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	7.86%
Pretax Margin	-409.03%
Profit Margin	-408%
EBITDA Margin	7.86%
EBIT Margin	7.86%
FCF Margin	-199.29%

Dividends & Yields

VACC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for VACC.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	2.83
Piotroski F-Score	3

Vaccitech (VACC)